These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9628456)

  • 1. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.
    Kolb SA; Lahrtz F; Paul R; Leppert D; Nadal D; Pfister HW; Fontana A
    J Neuroimmunol; 1998 Apr; 84(2):143-50. PubMed ID: 9628456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis.
    Sulik A; Wojtkowska M; Oldak E
    Scand J Immunol; 2008 Sep; 68(3):323-7. PubMed ID: 18565120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
    Matsuura E; Umehara F; Hashiguchi T; Fujimoto N; Okada Y; Osame M
    J Neurol Sci; 2000 Feb; 173(1):45-52. PubMed ID: 10675579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion.
    Azeh I; Mäder M; Smirnov A; Beuche W; Nau R; Weber F
    Neurosci Lett; 1998 Nov; 256(3):127-30. PubMed ID: 9855356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of purulent meningitis on the changes of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase inhibitor-1 (TIMP-1) in cerebrospinal fluid of neonates.
    Cui W; Luo X; Zhang Y
    Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2437-2441. PubMed ID: 31894031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis.
    Sulik A; Chyczewski L
    Folia Histochem Cytobiol; 2008; 46(4):437-42. PubMed ID: 19141395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
    Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
    Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA
    Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.
    Lindberg RL; Sorsa T; Tervahartiala T; Hoffmann F; Mellanen L; Kappos L; Schaad UB; Leib SL; Leppert D
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):304-17. PubMed ID: 16640649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
    Umehara F; Okada Y; Fujimoto N; Abe M; Izumo S; Osame M
    J Neuropathol Exp Neurol; 1998 Sep; 57(9):839-49. PubMed ID: 9737547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.
    Rosenberg GA; Dencoff JE; Correa N; Reiners M; Ford CC
    Neurology; 1996 Jun; 46(6):1626-32. PubMed ID: 8649561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia.
    Conant K; McArthur JC; Griffin DE; Sjulson L; Wahl LM; Irani DN
    Ann Neurol; 1999 Sep; 46(3):391-8. PubMed ID: 10482270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
    Price NM; Farrar J; Tran TT; Nguyen TH; Tran TH; Friedland JS
    J Immunol; 2001 Mar; 166(6):4223-30. PubMed ID: 11238675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.
    Leppert D; Ford J; Stabler G; Grygar C; Lienert C; Huber S; Miller KM; Hauser SL; Kappos L
    Brain; 1998 Dec; 121 ( Pt 12)():2327-34. PubMed ID: 9874483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and their inhibitors.
    Kugler A
    Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.